Standards for Reporting Prognostic Tumor Marker Studies
- 20 December 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (36), 9053-9054
- https://doi.org/10.1200/jco.2005.04.3778
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Reporting Recommendations for Tumor Marker Prognostic StudiesJournal of Clinical Oncology, 2005
- High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' TumorJournal of Clinical Oncology, 2005
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004
- The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.JNCI Journal of the National Cancer Institute, 2003
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeClinical Chemistry, 2003
- Phases of Biomarker Development for Early Detection of CancerJNCI Journal of the National Cancer Institute, 2001
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJama-Journal Of The American Medical Association, 2001